{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T07:41:15Z","timestamp":1751787675040},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Septic shock is when initial fluid resuscitation fails to increase the mean atrial pressure to greater than or equal to 65\u2009mm Hg. The 2021 Surviving Sepsis Campaign guidelines recommend corticosteroids for vasopressor and fluid-refractory septic shock patients. Medication shortages can arise, and their etiologies include natural disasters, quality control issues, and manufacturing discontinuation. The U.S. Food and Drug Administration and the American Society of Health-System Pharmacists announced a shortage of IV hydrocortisone. Methylprednisolone and dexamethasone are considered therapeutic alternatives to hydrocortisone. This commentary aims to guide clinicians on the alternative to hydrocortisone among septic shock patients due to medication shortage.<\/jats:p>","DOI":"10.1097\/cce.0000000000000940","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T20:55:38Z","timestamp":1687640138000},"page":"e0940","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage"],"prefix":"10.1097","volume":"5","author":[{"given":"Mohammed","family":"Aldhaeefi","sequence":"first","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Alshaya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia"},{"name":"Department of Pharmaceutical Care, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, KSA"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa","family":"Belrhiti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Howard University Hospital, Washington, DC 20060, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhakrit","family":"Rungkitwattanakul","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages.","volume":"75","author":"Fox","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids.","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"e2029323","DOI":"10.1001\/jamanetworkopen.2020.29323","article-title":"Smarter use of corticosteroids in treating patients with septic shock.","volume":"3","author":"Prescott","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18700\/jnc.170035","article-title":"Pharmacologic characteristics of corticosteroids.","volume":"10","author":"Samuel","year":"2017","journal-title":"J Neurocrit Care"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2016.00070","article-title":"The role of ACTH and corticosteroids for sepsis and septic shock: An update.","volume":"7","author":"Annane","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock.","volume":"5","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock.","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: The HYPRESS randomized clinical trial.","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"2","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Early administration of hydrocortisone replacement after the advent of septic shock: Impact on survival and immune response*.","volume":"42","author":"Katsenos","year":"2014","journal-title":"Crit Care Med"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/S1516-31802007000400009","article-title":"Early dexamethasone treatment for septic shock patients: A prospective randomized clinical trial.","volume":"125","author":"Cicarelli","year":"2007","journal-title":"Sao Paulo Med J"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock.","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:10:07Z","timestamp":1723025407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000940","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2023,6,23]]}}}